VAV targets 40% LatAM market share in 5 years with high-purity lipids

Photo:Representative Image

VAV Lipids, one of the world's leading lipid producers, plans to expand into Latin America. The company distributes its pure lipid ingredients to pharmaceutical, pharmaceutical, and cosmetic manufacturers through well-known local distributors in Mexico, Brazil, Argentina, Peru, and Colombia.

VAV Lipids is headquartered in Mumbai, India, and is one of the most important companies in the world. Famous builders.One of them. Phospholipids and lecithin. The biopharmaceutical company produces vegetable phospholipids (LECIVA), egg phospholipids (LIPOVA), synthetic phospholipids, and neutral lipids. Other products include APIs and specialty proteins.

VAV's advanced phospholipids and lecithins are raw materials for developing bioactive drug delivery systems (NDDS). Pharmaceutical companies use high-quality lipids to create a variety of drug delivery and biological agents. These include using lipids in developing vaccines, anesthesia, synthetic, liposome-based cancer treatments, and new drug delivery systems to treat many diseases. The products are also used in skincare, personal care, and hair care products.

VAV Lipids distributes all types of products through the company's Latin American distribution network. The company offers distribution with technical and marketing training. The company also provides customers with end-to-end technical support, including training sessions and webinars. This includes technical assistance in choosing the right grade of lecithin and phospholipid and guidance on formulation, application, analytical methods, and stability.

Arun Kedia, Managing Director of VAV Lipids, said: “Expansion into Latin America strengthens our global presence. Beautiful. This will also benefit the medical, pharmaceutical, and cosmetic industries. Latin America has a large market but is currently lacking as there are few lipid producers worldwide. VAV Lipids meets this unsatisfied demand for high-quality ingredients."

The estimate of VAV products in the Latin American market is more than 50 million dollars. He added that the company demands to grow strongly in this market and capture 40% of the market share in the next five years.